{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:17:07Z","timestamp":1789953427583,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":1260,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["11\/PI\/1066"],"award-info":[{"award-number":["11\/PI\/1066"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1111\/jth.14471","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T12:03:47Z","timestamp":1557144227000},"page":"1018-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["von Willebrand factor sialylation\u2014A critical regulator of biological function"],"prefix":"10.1016","volume":"17","author":[{"given":"Soracha","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie M.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14471_bb0010","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor\u00a0VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/jth.14471_bb0020","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMc1616060","article-title":"von Willebrand's disease. Longo DL, editor","volume":"376","author":"Leebeek","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14471_bb0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14471_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","article-title":"Elevated factor\u00a0VIII levels and risk of venous thrombosis","volume":"157","author":"Jenkins","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14471_bb0035","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2012-10-415000","article-title":"Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities","volume":"121","author":"Preston","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1991.tb43700.x","article-title":"von Willebrand factor biosynthesis and processing","volume":"614","author":"Mayadas","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/jth.14471_bb0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2141.2009.08052.x","article-title":"Platelet von Willebrand factor\u2014structure, function and biological importance","volume":"148","author":"McGrath","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14471_bb0050","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/s-0037-1615018","article-title":"Post\u2010translational modifications required for coagulation factor secretion and function","volume":"79","author":"Kaufman","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0055","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/bi00359a015","article-title":"Amino acid sequence of human von Willebrand factor","volume":"25","author":"Titani","year":"1986","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14471_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BJ20120810","article-title":"Mapping the N\u2010glycome of human von Willebrand factor","volume":"447","author":"Canis","year":"2012","journal-title":"Biochem J"},{"key":"10.1111\/jth.14471_bb0065","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2009-09-241547","article-title":"Expression of terminal alpha2\u20106\u2010linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13","volume":"115","author":"McGrath","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01047846","article-title":"Primary structure of the major O\u2010glycosidically linked carbohydrate unit of human von Willebrand factor","volume":"6","author":"Samor","year":"1989","journal-title":"Glycoconj J"},{"key":"10.1111\/jth.14471_bb0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1538-7836.2009.03665.x","article-title":"The plasma von Willebrand factor O\u2010glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs","volume":"8","author":"Canis","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0080","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jth.13260","article-title":"Site\u2010specific analysis of von Willebrand factor O\u2010glycosylation","volume":"14","author":"Solecka","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0085","doi-asserted-by":"crossref","first-page":"13657","DOI":"10.1073\/pnas.1515464112","article-title":"An intrinsic mechanism of secreted protein aging and turnover","volume":"112","author":"Yang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14471_bb0090","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2018-09-874636","article-title":"Increased galactose expression and enhanced clearance in patients with low von Willebrand factor","volume":"133","author":"Aguila","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0095","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1182\/blood-2006-06-032706","article-title":"Variations in glycosylation of von Willebrand factor with O\u2010linked sialylated T antigen are associated with its plasma levels","volume":"109","author":"van Schooten","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0100","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1055\/s-0037-1613123","article-title":"Heterogeneous detection of A\u2010antigen on von Willebrand factor derived from platelets, endothelial cells and plasma","volume":"87","author":"Brown","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0049-3848(74)90218-7","article-title":"Factor\u2010VIII\u2010related antigen in platelets","volume":"4","author":"Howard","year":"1974","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14471_bb0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.141.5.1101","article-title":"Subcellular platelet factor\u00a0VIII antigen and von Willebrand factor","volume":"141","author":"Nachman","year":"1975","journal-title":"J Exp Med"},{"key":"10.1111\/jth.14471_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2141.1994.tb05077.x","article-title":"Purification and characterization of human platelet von Willebrand factor","volume":"88","author":"Williams","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14471_bb0120","first-page":"51","article-title":"A preliminary analysis of platelet von Willebrand factor oligosaccharides","volume":"63","author":"Kagami","year":"2000","journal-title":"Nagoya J Med Sci"},{"key":"10.1111\/jth.14471_bb0125","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1182\/blood-2013-04-496851","article-title":"Altered glycosylation of platelet\u2010derived von Willebrand factor confers resistance to ADAMTS13 proteolysis","volume":"122","author":"McGrath","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood.V71.4.947.947","article-title":"Adhesive properties of the carbohydrate\u2010modified von Willebrand factor (CHO\u2010vWF)","volume":"71","author":"Federici","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2012-02-410050","article-title":"O\u2010linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein\u00a0Ib under static and shear stress conditions","volume":"120","author":"Nowak","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0140","doi-asserted-by":"crossref","first-page":"44124","DOI":"10.1063\/1.4819746","article-title":"Circulating but not immobilized N\u2010deglycosylated von Willebrand factor increases platelet adhesion under flow conditions","volume":"7","author":"Fallah","year":"2013","journal-title":"Biomicrofluidics"},{"key":"10.1111\/jth.14471_bb0145","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood.V72.5.1790.1790","article-title":"Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino\u2010terminal proteolytic cleavage","volume":"72","author":"Berkowitz","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0150","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1073\/pnas.92.7.2428","article-title":"Platelet von Willebrand factor in inherited and acquired bleeding disorders","volume":"92","author":"Mannucci","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14471_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1111\/jth.14471_bb0165","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.113.006727","article-title":"Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy","volume":"129","author":"Tersteeg","year":"2014","journal-title":"Circulation"},{"key":"10.1111\/jth.14471_bb0170","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/ATVBAHA.116.308524","article-title":"Plasmin cleaves von Willebrand factor at K1491\u2010R1492 in the A1\u2013A2 linker region in a shear\u2010 and glycan\u2010dependent manner in\u00a0vitro","volume":"37","author":"Brophy","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14471_bb0175","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood-2013-06-498303","article-title":"von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy","volume":"122","author":"Lillicrap","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0180","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2007-06-095042","article-title":"N\u2010linked glycosylation of VWF modulates its interaction with ADAMTS13","volume":"111","author":"McKinnon","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0185","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/jth.13044","article-title":"Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear\u2010induced platelet activation","volume":"13","author":"Herbig","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance\u2014biological mechanisms and clinical significance","volume":"183","author":"O'Sullivan","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14471_bb0195","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1016\/S0021-9258(19)63384-3","article-title":"Relationship of sialic acid to function and in\u00a0vivo survival of human factor\u00a0VIII\/von Willebrand factor protein","volume":"252","author":"Sodetz","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14471_bb0200","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in\u00a0vivo survival of von Willebrand factor","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.14471_bb0205","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood.V88.5.1692.1692","article-title":"Clearance of normal and type\u00a02A von Willebrand factor in the rat","volume":"88","author":"Stoddart","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0210","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/jth.13537","article-title":"N\u2010linked glycan truncation causes enhanced clearance of plasma\u2010derived von Willebrand factor","volume":"14","author":"O'Sullivan","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0215","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.142005099","article-title":"Sialyltransferase ST3Gal\u2010IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands","volume":"99","author":"Ellies","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14471_bb0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2017-06-787853","article-title":"A novel role for the macrophage galactose\u2010type lectin receptor in mediating von Willebrand factor clearance","volume":"131","author":"Ward","year":"2018","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/jth.14471_bb0230","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood-2016-04-709436","article-title":"N\u2010linked glycans within the A2 domain of von Willebrand factor modulate macrophage\u2010mediated clearance","volume":"128","author":"Chion","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","article-title":"Carbohydrate\u2010specific receptors of the liver","volume":"51","author":"Ashwell","year":"1982","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/jth.14471_bb0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/physrev.1995.75.3.591","article-title":"The asialoglycoprotein receptor: relationships between structure, function, and expression","volume":"75","author":"Stockert","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1111\/jth.14471_bb0245","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1021\/bi00192a021","article-title":"Interaction of immobilized recombinant mouse C\u2010type macrophage lectin with glycopeptides and oligosaccharides","volume":"33","author":"Yamamoto","year":"1994","journal-title":"Biochemistry"},{"key":"10.1111\/jth.14471_bb0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/intimm\/dxf021","article-title":"Human macrophage lectin specific for galactose\/N\u2010acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages","volume":"14","author":"Higashi","year":"2002","journal-title":"Int Immunol"},{"key":"10.1111\/jth.14471_bb0255","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3324\/haematol.2012.063297","article-title":"Factor\u00a0VIII and von Willebrand factor are ligands for the carbohydrate\u2010receptor Siglec\u20105","volume":"97","author":"Pegon","year":"2012","journal-title":"Haematologica"},{"key":"10.1111\/jth.14471_bb0260","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome\u2010wide association transethnic meta\u2010analyses identifies novel associations regulating coagulation factor\u00a0VIII and von Willebrand factor plasma levels","volume":"139","author":"Sabater\u2010Lleal","year":"2019","journal-title":"Circulation"},{"key":"10.1111\/jth.14471_bb0265","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH07-09-0565","article-title":"Survival of von Willebrand factor released following DDAVP in a type\u00a01 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations","volume":"99","author":"Millar","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0270","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0275","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2958.1993.tb01221.x","article-title":"The sialidase superfamily and its spread by horizontal gene transfer","volume":"9","author":"Roggentin","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1111\/jth.14471_bb0280","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1172\/JCI27920","article-title":"Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production","volume":"116","author":"Soong","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.14471_bb0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/jth.14471_bb0290","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1055\/s-0037-1613892","article-title":"Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension","volume":"83","author":"Lopes","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0295","doi-asserted-by":"crossref","first-page":"e112935","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor\u2010associated parameters are acquired during uncomplicated pregnancy.","volume":"9","author":"Drury\u2010Stewart","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.14471_bb0300","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/rth2.12166","article-title":"Evaluation of von Willebrand factor concentrates by platelet adhesion to collagen using an in\u00a0vitro flow assay","volume":"3","author":"Riddell","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1111\/jth.14471_bb0305","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/asheducation-2016.1.683","article-title":"New treatment approaches to von Willebrand disease","volume":"2016","author":"Lavin","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.14471_bb0310","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1055\/s-0037-1617202","article-title":"Development of a plasma\u2010 and albumin\u2010free recombinant von Willebrand factor","volume":"29","author":"Turecek","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.14471_bb0315","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma\u2010free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14471_bb0320","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14471","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14471","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622143710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622143710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:15:20Z","timestamp":1761534920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622143710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1538783622143710"],"URL":"https:\/\/doi.org\/10.1111\/jth.14471","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand factor sialylation\u2014A critical regulator of biological function","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}